🇮🇳 India Stock Screener ← Switch market ⚡ HerAI

Bharat Parenterals Limited BPLPHARMA NSEPHARMA

Healthcare · Drug Manufacturers - Specialty & Generic · India
https://bplindia.in
Company Profile ↓
₹1,758.80
+39.15% 1Y
Mkt Cap₹1,212.16 Cr
P/E-78.48
P/B2.39
Div. Yield0.05%
52W High₹2,149.80
52W Low₹1,263.99
Book Value₹795.60
EPS (TTM)₹-22.41

Company Overview

Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally. The company provides antibiotics, cardiovascular and central nervous system, antifungal, antimalarial, gastrointestinal tract/alimentary systems, analgesics, anaesthetics, quinolones, erectile dysfunction medicines, nutritional supplements, steroids and hormones, and other drugs. It also engages in manufacturing general products in capsules, tablets, ointment and creams, injections, oral liquids, and powder sachets forms; and beta lactum and cephalosporin products in capsules, tablets, dry syrup, and powder for injection forms. In addition, it offers research, development and manufacture of pharmaceutical formula ons, including sterile injectable products, oral liquid formula ons, prefilled syringes, other specialty, and eye drops. Bharat Parenterals Limited was incorporated in 1992 and is based in Vadodara, India.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 16.7% CAGR over the past five years.

Recent Developments

  • Mar 2026 Revenue of ₹345.43 Cr (+1.5% YoY); net profit ₹-8.19 Cr.
  • Trailing 12 Months Year-on-year growth — revenue -19.2%.
  • 5-Year Trend Long-term compounding — revenue CAGR 16.7%, profit CAGR -49.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:16.66%
1 Year:-19.20%

Compounded Profit Growth

5 Years:-49.93%
1 Year:-

Stock Price Performance

1 Year:+39.15%
6 Months:-
3 Months:-
1 Month:+16.50%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot
52-Week Range 56% of range
₹1,263.99 ₹2,149.80
Trend Signals
  • RSI (14)51.64 · Neutral
Price Performance
1M+16.50%
1Y+39.15%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 16.7% over 5 years.

CONS

  • Earnings shrank at -49.9% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-78.48
Industry PE
36.43
Forward P/E
-
PEG Ratio
-
Book Value
₹795.60
Price to Book
2.39
P/S
2.79
EV/EBITDA
139.52
Dividend Yield
0.05%

Growth (CAGR)

Revenue 5Y
16.66%
Profit 5Y
-49.93%
Revenue (YoY)
-19.20%
Earnings (YoY)
-

Profitability & Returns

ROCE
-4.04%
ROE
-2.54%
ROA
-1.33%
Profit Margin
-4.77%
Op Margin
-0.16%
Gross Margin
47.75%
EPS (Latest Qtr)
₹-
EPS (TTM)
₹-22.41

Balance Sheet & Liquidity

Debt/Equity
0.47
Quick Ratio
1.43
Current Ratio
1.97
Debt
₹146.11 Cr
Total Assets
₹613.30 Cr
Current Assets
₹310.08 Cr
Working Capital
₹152.69 Cr

Ownership

Promoter Holding
79.74%
Chg in Prom Hold
-
FII / Inst Holding
0.04%
Chg in FII Hold
0.04%

Financial Snapshot

Enterprise Value
₹1,212.16 Cr
Total Revenue (TTM)
₹323.17 Cr
EBITDA
₹10.23 Cr
Free Cash Flow
₹-1.57 Cr
Operating Cash Flow
₹38.36 Cr
Shares Outstanding
₹68.92 L
Gross Margin
47.75%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 BPLPHARMA Bharat Parenterals Limited NSEPHARMA 1,758.80 -78.48 ₹1,212.16 Cr 0.05% -4.04% -2.54% 16.66% -49.93%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,745.10 34.62 ₹4.19 L Cr 0.91% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 9,190.00 83.58 ₹2.44 L Cr 0.32% 18.96% 15.32% 10.98% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,553.80 72.74 ₹1.73 L Cr 0.81% 9.05% 25.79% 13.27% 20.22%
5 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,117.30 24.90 ₹1.11 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
6 LENSKART Lenskart Solutions Limited NIFTY_MIDNSEPHARMA 631.35 164.41 ₹1.09 L Cr 0.00% 7.21% 5.65% 35.38% 66.99%
7 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 7,600.00 52.32 ₹1.09 L Cr 0.25% 19.20% 20.48% 14.85% 33.34%
8 LAURUSLABS Laurus Labs Limited NIFTY_MIDNSEPHARMA 2,012.50 99.48 ₹1.09 L Cr 0.12% 19.53% 16.77% 3.77% 4.00%
9 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,314.00 31.51 ₹1.06 L Cr 0.99% 14.86% 11.27% 7.23% 11.45%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 103.98 Cr116.00 Cr64.62 Cr65.19 Cr99.62 Cr
Cost of Revenue 53.54 Cr68.85 Cr26.92 Cr32.31 Cr57.75 Cr
Gross Profit 50.44 Cr47.15 Cr37.70 Cr32.88 Cr41.87 Cr
Operating Expenses 56.73 Cr41.97 Cr45.44 Cr39.60 Cr51.02 Cr
Operating Income -6.28 Cr5.18 Cr-7.74 Cr-6.71 Cr-9.15 Cr
EBITDA 4.16 Cr14.84 Cr4.36 Cr3.07 Cr3.10 Cr
Interest Expense 3.94 Cr3.69 Cr3.11 Cr2.90 Cr2.85 Cr
Pretax Income -8.30 Cr2.55 Cr-7.31 Cr-8.28 Cr-8.37 Cr
Tax Provision 1.14 Cr3.42 Cr1.29 Cr1.39 Cr-21.19 L
Net Income -4.73 Cr8.23 Cr-7.24 Cr-5.28 Cr-4.80 Cr
Diluted EPS -----

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -217.56 Cr257.05 Cr340.38 Cr345.43 Cr
Cost of Revenue -145.58 Cr168.53 Cr199.64 Cr191.40 Cr
Gross Profit -71.99 Cr88.52 Cr140.74 Cr154.04 Cr
Operating Expenses -56.26 Cr70.42 Cr173.36 Cr172.47 Cr
Operating Income -15.73 Cr18.10 Cr-32.62 Cr-18.43 Cr
EBITDA -31.62 Cr30.92 Cr14.32 Cr25.36 Cr
Interest Expense -2.19 Cr3.18 Cr12.95 Cr12.53 Cr
Pretax Income -23.55 Cr18.72 Cr-33.95 Cr-21.42 Cr
Tax Provision -7.83 Cr8.21 Cr9.72 Cr5.88 Cr
Net Income -16.44 Cr14.52 Cr-12.63 Cr-8.19 Cr
Diluted EPS -28.4024.94-66.64-39.62

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -350.34 Cr504.04 Cr648.53 Cr613.30 Cr
Current Assets -184.28 Cr262.00 Cr355.52 Cr310.08 Cr
Cash & Equivalents -7.85 Cr8.71 Cr56.00 L1.48 Cr
Inventory -37.84 Cr61.47 Cr71.95 Cr84.72 Cr
Receivables -112.41 Cr141.42 Cr171.74 Cr150.65 Cr
Total Liabilities -132.44 Cr265.87 Cr309.53 Cr301.72 Cr
Current Liabilities -119.80 Cr189.83 Cr219.30 Cr157.39 Cr
Long Term Debt -10.92 Cr73.16 Cr75.87 Cr121.79 Cr
Total Debt -49.74 Cr157.58 Cr180.20 Cr146.11 Cr
Total Equity -182.80 Cr197.27 Cr330.67 Cr322.23 Cr
Shares Outstanding -57.75 L58.20 L68.92 L68.92 L

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -21.66 Cr-4.71 Cr-27.25 Cr38.36 Cr
Investing Cash Flow --77.82 Cr-104.78 Cr-137.38 Cr9.32 Cr
Financing Cash Flow -60.60 Cr110.43 Cr156.37 Cr-47.05 Cr
Capital Expenditure --91.60 Cr-104.30 Cr-29.08 Cr-39.93 Cr
Free Cash Flow --69.94 Cr-109.01 Cr-56.33 Cr-1.57 Cr
Net Change in Cash -4.44 Cr93.81 L-8.27 Cr63.68 L

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -33.1%34.4%41.3%44.6%
Operating Margin % -7.2%7.0%-9.6%-5.3%
Net Margin % -7.6%5.6%-3.7%-2.4%
ROE % -9.0%7.4%-3.8%-2.5%
ROCE % -6.8%5.8%-7.6%-4.0%

Shareholding Pattern

Insiders
79.74%
Institutions
0.04%
Public Float
0.18%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for BPLPHARMA

Google News ue, 29 Sep 2026

Bharat Parenterals Share Price Update After Sharp Decline - Univest

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxOZ29RYXJ5VnRuaThPSDZ2MmsxUUxlV01QX2sxdmQ4d0JmSmlyQUFQTmx5cWR4TXQ4cGVTWkZxd0pfZlk2cGtDeHMzYkxuQ3oxX3g2elpibkRTZlNPOXFnM3hOU1diUEJiMWVrR05BVkwydm96YW9JUjYyUjJQS05Bcg?oc=5" target="_…

Google News ue, 29 Sep 2026

Bharat Parenterals Ltd (NSE: BPLPHARMA) Declines 5.67% as Stock Draws Market Attention - Kalkine India

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOeS1PWFBqVnA4WHN6VG5CWVpaYmhfWTJzMjBhMWFqSFJJMUlEcm9qR3J4dzkteW9UQzRNZ1gxcVQ3SHJNY1NYWkUwb3VLOHZIcFBEY0JEMnFpdzh3LTNvQTdnWWtLV0k5Yi1EYlVJVHVMOHNoRmVDUDA4UW1SeWZMWEtHVUJGWmJnVVBqeV…

Google News Fri, 01 Mar 2024

BPLPHARMA Stock Price and Chart — NSE:BPLPHARMA - TradingView

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1xdUljQWtzNDVnVWFxWDhVY0ZvYVJBZmI4eHM2TXNaWE5IVV9ySUM1eVdwT2pIZWZHSGdiLVpUZEQ4VjJQZVVtS201Q1JrNUFrWmVhaEJxWFg1eVZyTGFZ?oc=5" target="_blank">BPLPHARMA Stock Price and Chart — NSE:B…

Google News hu, 06 May 2021

Bharat Parenterals Limited (BPLPHARMA.BO) Stock Price, News, Quote & History - Yahoo! Finance Canada

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE5HR2pKQlBRcmdpdEwwaEIwaWVQZDdESHFuNUxJdklXeXJEYVNMck5XbksxZHYzaGNETzBXbjNKWUE4SEY0dVJObG8wOWctUUVEenZXZUZXdmMtTXhN?oc=5" target="_blank">Bharat Parenterals Limited (BPLPHARMA.BO) S…

Google News ue, 06 Oct 2026

Bharat Parenterals Ltd. Share Price today after 9.58% rise - Univest

<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxNSWgzRkF2QXBSNlQ1N1h4SmNLVXo4UEdldU42ZDFBeW1HZXhRVGxlNVpKNVZuQmp4aEtVTG5Fd0JIa3BWVzYyck5XYVJvVUZ0V3hWaHpFWE1lNWRCRGhaLXExZ1JENFhkc1pyZE1lRnAtOG9HbVJNLUhndG56WWZ1dkpKSW02QQ?oc=5" t…

Google News Wed, 30 Sep 2026

Bharat Parenterals (NSE:BPLPHARMA) Approves ₹139 Crore Preferential Share Issue for Growth Initiatives - Kalkine India

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxPeHVQckJJbzNGZzNyRkczM3IyXzgwYlpydjUxc09ucDVuZDkyazk1eUVKN0g3UHFHNk9nc211T0VSZHoyWXFlQThrLVZOQldXVU9JRjZXMl9tR0dzNDQzblNnRFNUMkJmUmdSLXRDQmJkd1Q3ODk1WmtUZW1sLVI2cHUwcWNoWDdmT2tkND…

BPLPHARMA — Frequently Asked Questions

What is the current share price of Bharat Parenterals Limited (BPLPHARMA)?

As of 2026-10-23 04:58 IST, Bharat Parenterals Limited (BPLPHARMA) trades at ₹1,758.80 on NSE. Its 52-week range is ₹1,263.99 to ₹2,149.80.

What is the market capitalisation of BPLPHARMA?

Bharat Parenterals Limited (BPLPHARMA) has a market capitalisation of ₹1,212.16 Cr on NSE.

What is the P/E ratio of BPLPHARMA?

BPLPHARMA trades at a trailing price-to-earnings (P/E) ratio of -78.48. The industry average P/E is 36.43. Its price-to-book (P/B) ratio is 2.39.

Does BPLPHARMA pay a dividend?

Bharat Parenterals Limited (BPLPHARMA) currently offers a dividend yield of 0.05%.

What is the return on equity (ROE) of BPLPHARMA?

BPLPHARMA has a return on equity (ROE) of -2.54%. Its return on capital employed (ROCE) is -4.04%.

Is BPLPHARMA a good stock to buy?

This page provides a data-driven analysis of Bharat Parenterals Limited (BPLPHARMA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space